Xtant Medical Holdings Stock Profit Margin
| XTNT Stock | USD 0.40 0.01 2.44% |
Xtant Medical Holdings fundamentals help investors to digest information that contributes to Xtant Medical's financial success or failures. It also enables traders to predict the movement of Xtant Stock. The fundamental analysis module provides a way to measure Xtant Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Xtant Medical stock.
| Last Reported | Projected for Next Year | ||
| Net Profit Margin | 0.01 | 0.01 |
Xtant | Profit Margin |
Xtant Medical Holdings Company Profit Margin Analysis
Xtant Medical's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Xtant Medical Profit Margin | (0.03) % |
Most of Xtant Medical's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Xtant Medical Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Xtant Profit Margin Driver Correlations
Understanding the fundamental principles of building solid financial models for Xtant Medical is extremely important. It helps to project a fair market value of Xtant Stock properly, considering its historical fundamentals such as Profit Margin. Since Xtant Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Xtant Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Xtant Medical's interrelated accounts and indicators.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Xtant Pretax Profit Margin
Pretax Profit Margin |
|
Based on the latest financial disclosure, Xtant Medical Holdings has a Profit Margin of -0.03%. This is 99.73% lower than that of the Health Care Equipment & Supplies sector and 99.45% lower than that of the Health Care industry. The profit margin for all United States stocks is 97.64% lower than that of the firm.
Xtant Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Xtant Medical's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Xtant Medical could also be used in its relative valuation, which is a method of valuing Xtant Medical by comparing valuation metrics of similar companies.Xtant Medical is currently under evaluation in profit margin category among its peers.
Xtant Medical Current Valuation Drivers
We derive many important indicators used in calculating different scores of Xtant Medical from analyzing Xtant Medical's financial statements. These drivers represent accounts that assess Xtant Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Xtant Medical's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 21.1M | 34.1M | 47.9M | 62.1M | 134.6M | 141.3M | |
| Enterprise Value | 94.4M | 50.3M | 46.5M | 58.9M | 152.4M | 107.5M |
Xtant Fundamentals
| Return On Equity | -0.0877 | ||||
| Return On Asset | -0.11 | ||||
| Profit Margin | (0.03) % | ||||
| Operating Margin | (0.1) % | ||||
| Current Valuation | 84.96 M | ||||
| Shares Outstanding | 139.01 M | ||||
| Shares Owned By Insiders | 7.83 % | ||||
| Shares Owned By Institutions | 65.12 % | ||||
| Number Of Shares Shorted | 197.47 K | ||||
| Price To Earning | (0.41) X | ||||
| Price To Book | 1.22 X | ||||
| Price To Sales | 0.50 X | ||||
| Revenue | 91.3 M | ||||
| Gross Profit | 32.14 M | ||||
| EBITDA | 5.07 M | ||||
| Net Income | 660 K | ||||
| Cash And Equivalents | 16.5 M | ||||
| Cash Per Share | 0.19 X | ||||
| Total Debt | 23.56 M | ||||
| Debt To Equity | 0.60 % | ||||
| Current Ratio | 3.57 X | ||||
| Book Value Per Share | 0.39 X | ||||
| Cash Flow From Operations | (9.52 M) | ||||
| Short Ratio | 6.92 X | ||||
| Earnings Per Share | (0.13) X | ||||
| Price To Earnings To Growth | (0.03) X | ||||
| Target Price | 2.25 | ||||
| Number Of Employees | 207 | ||||
| Beta | 0.39 | ||||
| Market Capitalization | 55.6 M | ||||
| Total Asset | 92.61 M | ||||
| Retained Earnings | (243.01 M) | ||||
| Working Capital | 41.88 M | ||||
| Current Asset | 45.04 M | ||||
| Current Liabilities | 21.47 M | ||||
| Net Asset | 92.61 M |
About Xtant Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Xtant Medical Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Xtant Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Xtant Medical Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Xtant Stock Analysis
When running Xtant Medical's price analysis, check to measure Xtant Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xtant Medical is operating at the current time. Most of Xtant Medical's value examination focuses on studying past and present price action to predict the probability of Xtant Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xtant Medical's price. Additionally, you may evaluate how the addition of Xtant Medical to your portfolios can decrease your overall portfolio volatility.